Cookson Peirce & Co’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Buy |
9,582
+667
| +7% | +$75.8K | 0.05% | 150 |
|
|
2025
Q1 | $937K | Buy |
8,915
+1,265
| +17% | +$133K | 0.05% | 140 |
|
|
2024
Q4 | $820K | Buy |
7,650
+2,755
| +56% | +$295K | 0.04% | 150 |
|
|
2024
Q3 | $490K | Buy |
4,895
+1,554
| +47% | +$156K | 0.02% | 186 |
|
|
2024
Q2 | $282K | Buy |
+3,341
| New | +$282K | 0.01% | 209 |
|
|
2016
Q3 | – | Sell |
-103,474
| Closed | -$7.7M | – | 150 |
|
|
2016
Q2 | $7.7M | Sell |
103,474
-11,221
| -10% | -$835K | 1.14% | 32 |
|
|
2016
Q1 | $7.66M | Sell |
114,695
-513
| -0.4% | -$34.3K | 1.21% | 31 |
|
|
2015
Q4 | $7.79M | Buy |
115,208
+257
| +0.2% | +$17.4K | 1.17% | 32 |
|
|
2015
Q3 | $6.14M | Buy |
+114,951
| New | +$6.14M | 1.02% | 36 |
|